| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 16 |
| 1 | TADALAFIL | 13 |
| 2 | BOSENTAN | 12 |
| 3 | SILDENAFIL | 10 |
| 4 | SILDENAFIL CITRATE | 10 |
| 5 | SILDENAFIL POWDER, | 10 |
| 6 | MACITENTAN | 7 |
| 7 | AMBRISENTAN | 6 |
| 8 | ESOMEPRAZOLE | 2 |
| 9 | ESOMEPRAZOLE MAGNESIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 16 | 0.0012 |
| 1 | ZOLBETUXIMAB | 1 | 0.0007 |
| 2 | SILDENAFIL POWDER, | 10 | 0.0003 |
| 3 | BOSENTAN | 12 | 0.0002 |
| 4 | CABERGOLINE | 1 | 0.0002 |
| 5 | TADALAFIL | 13 | 0.0001 |
| 6 | LUBIPROSTONE | 1 | 0.0001 |
| 7 | MACITENTAN | 7 | 0.0001 |
| 8 | SILDENAFIL CITRATE | 10 | 0.0001 |
| 9 | RIOCIGUAT | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 1 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 23 | 0.0002 |
| 3 | Prostacycline Vasodilator [EPC] | 16 | 0.0001 |
| 4 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 5 | Endothelin Receptor Antagonist [EPC] | 13 | 0.0001 |
| 6 | Soluble Guanylate Cyclase Stimulator [EPC] | 2 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | Dietary Cholesterol Absorption Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |